Skip to content

The anabolic effect of protein supplementation during an exercise training program in elderly men

The impact of protein supplementation to maximize the skeletal muscle adaptive response to resistance type exercise training in healthy elderly men

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON26272
Enrollment
40
Registered
2015-03-06
Start date
2015-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia

Interventions

- Resistance Exercise - Protein supplementation post-exercise and pre-sleep - Placebo supplementation post-exercicse and pre-sleep

Sponsors

Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: • Healthy males • Age between 65 and 80 y • BMI between 18.5 and 30 kg/m2 • Moderately active, performing fitness or sports on a non-competitive basis 1 time or less than 2 hours per week

Exclusion criteria

Exclusion criteria: • HbA1C level above 6.5% • Fasted blood glucose level above 6.9 mmol/L • Celiac disease • Lactose intolerance • Smoking • Diabetes • Cancer • Cardiovascular Disease • Diagnosed GI tract diseases • Arthritic conditions • A history of neuromuscular problems • Cognitive Impairment • COPD • Renal disorder • Any medications known to affect protein metabolism (i.e. corticosteroids, non-steroidal anti-inflammatories, or prescription strength acne medications). • Participation in exercise program • Hypertension, high blood pressure that is above 140/90 mmHg.

Design outcomes

Primary

MeasureTime frame
- Quadriceps cross sectional area

Secondary

MeasureTime frame
- Muscle fibre cross sectional area - Body composition - Muscle Strength - Physical Performance - Muscle protein synthesis

Contacts

Public ContactA. Holwerda

Universiteitssingel 50

andy.holwerda@maastrichtuniversity.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)